Internal Medicine, Hematology & Oncology · Annapolis, MD
NPI
1912292517
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2003 Medical Pkwy Ste 210
Annapolis, MD, 21401
Phone (410) 573-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
227,421 services
Medicare patients, 2024
666
Average age 75
Drug cost, 2024
$2.3M
1,625 prescriptions
Company payments, 2025
$517
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam J Goldrich was code J9271 (injection, pembrolizumab, 1 mg), 39,000 times for 38 patients. In total Adam J Goldrich billed 227,421 services in 176 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 39,000 | 38 | $44.60 | $1.7M |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 18,200 | 14 | $0.06 | $1,029 |
| J0185 Injection, aprepitant, 1 mg | Office | 17,550 | 40 | $1.34 | $24K |
| J9299 Injection, nivolumab, 1 mg | Office | 11,880 | 12 | $24.47 | $291K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,450 | 26 | $0.11 | $708 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,718 | 16 | $0.08 | $460 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,978 | 106 | $0.09 | $266 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,700 | 19 | $15.94 | $43K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,075 | 72 | $0.72 | $1,502 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,982 | 20 | $3.55 | $7,034 |
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 13 | $20.46 | $38K |
| 85025 Blood Count | Office | 1,851 | 346 | $7.59 | $14K |
| 80053 Clinical Chemistry | Office | 1,641 | 326 | $10.35 | $17K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,248 | 25 | $2.31 | $2,885 |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 920 | 12 | $0.07 | $66.39 |
By year: 2022 $3.9M for 185,841 services; 2023 $3.6M for 161,398 services; 2024 $4.9M for 227,421 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,851 | 346 | $7.59 | $14K |
| 80053 Clinical Chemistry | 1,641 | 326 | $10.35 | $17K |
| 88185 Surgical Pathology Examination | 506 | 15 | $21.97 | $11K |
| 82784 Immunoassay | 306 | 63 | $9.11 | $2,789 |
| 83735 Clinical Chemistry | 242 | 45 | $6.57 | $1,590 |
| 82565 Clinical Chemistry | 168 | 60 | $5.02 | $843 |
| 82728 Clinical Chemistry | 160 | 113 | $13.36 | $2,138 |
| 83540 Clinical Chemistry | 159 | 113 | $6.34 | $1,008 |
| 83550 Clinical Chemistry | 159 | 113 | $8.57 | $1,363 |
| 83615 Clinical Chemistry | 139 | 57 | $5.92 | $823 |
Medicare prescription drug claims, 2024
In 2024, the drug Adam J Goldrich prescribed most often to Medicare patients was Anastrozole, with 85 prescriptions and refills. In total Adam J Goldrich wrote 1,625 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 85 | 231 | 27 | $2,389 |
| Ondansetron Odt Ondansetron | 75 | 75 | 55 | $1,218 |
| Prednisone Generic | 75 | 141 | 26 | $609 |
| Oxycodone Hcl Generic | 66 | 66 | 24 | $851 |
| Dexamethasone Generic | 61 | 80 | 44 | $1,396 |
| Escitalopram Oxalate Generic | 50 | 106 | 18 | $533 |
| Eliquis Apixaban | 48 | 70 | 12 | $40K |
| Levothyroxine Sodium Generic | 47 | 99 | 15 | $505 |
| Prochlorperazine Maleate Generic | 43 | 43 | 30 | $584 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 40 | 41 | 35 | $442 |
| Gabapentin Generic | 39 | 62 | 14 | $360 |
| Pantoprazole Sodium Generic | 36 | 106 | 22 | $598 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 67 | 19 | $198 |
| Abiraterone Acetate Generic | 32 | 32 | Under 11 | $71K |
| Letrozole Generic | 30 | 60 | Under 11 | $682 |
Brand drugs: 258 claims; generic drugs: 1,367 claims; opioid claims: 127.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam J Goldrich $517 ($517 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $165.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $165 |
| Abbvie Inc. ABBV | 2 | $54.39 |
| Genentech, Inc. ROG.SW | 1 | $53.45 |
| Iovance Biotherapeutics, Inc. IOVA | 1 | $37.05 |
| GlaxoSmithKline, LLC. GSK | 1 | $34.26 |
| Azurity Pharmaceuticals, Inc. | 1 | $31.88 |
| Astellas Pharma US Inc 4503.T | 1 | $30.31 |
| Celgene Corporation BMY | 1 | $26.34 |
| Telix Pharmaceuticals TLX | 1 | $22.5 |
| Bioprotect Medical, Inc. | 1 | $21.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.